Rangeley Capital’s Repare Therapeutics RPTX Stock Holding History

Rangeley Capital’s Portfolio RPTX Stock Details RPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,287,829	Closed	-$3.35M	–	159
2025 Q4	$3.35M	Buy	1,287,829 +641,953	+99%	+$1.29M	2.78%	9
2025 Q3	$1.14M	Buy	645,876 +290,584	+82%	+$465K	0.98%	24
2025 Q2	$494K	Buy	+355,292	New	+$464K	0.59%	36

Rangeley Capital's RPTX Position: Q1 2026 in Review

Rangeley Capital sold out of Repare Therapeutics (RPTX) in Q1 2026, closing a stake of 1,287,829 shares — an estimated $3.35M sold.

Rangeley Capital first reported a position in RPTX in Q2 2025 and held it in 3 quarters. The position peaked at $3.35M in Q4 2025. 0 funds tracked by Wall St. Rank hold RPTX as of Q1 2026.

Rangeley Capital reported no remaining Repare Therapeutics position as of Q1 2026 after selling out during the quarter.
Rangeley Capital sold 1,287,829 Repare Therapeutics shares in Q1 2026, an estimated $3.35M.
Rangeley Capital first reported a position in Repare Therapeutics in Q2 2025 and held it in 3 quarters.
Rangeley Capital's Repare Therapeutics position peaked at $3.35M in Q4 2025.
0 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2026.

Based on Rangeley Capital's 13F filing for Q1 2026, filed 15 May 2026.